TreeWAS
Search
Variant clusters
Hospitalization Episode Statistics (HES)
Genetic variants: 36,212
Diagnostic terms: × 19,155
Association results: = 693,640,860
Self-Reported Statistics (SRS)
Genetic variants: 28,458
Diagnostic terms: × 474
Association results: = 13,489,092
About
Frequently Asked Questions
Citation
Download association data
for this variant in csv format
Share this page

Variant-specific associations

rs10865541
log Bayes Factor = <0.0001
Chromosome 2   position 3,392,075  (GRCh37) Explore rs10865541 on Ensembl!
Variant rs10865541 is listed in the   GWAS Catalog   ⇪

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)
Hierarchical visualisation How to interpret this figure?
Associations at terminal nodes are shown if p(effect) ≥
Click here to show this figure without filtering.
Click on a node to zoom (except terminal nodes).
Download this figure in format
Results table
Term Risk
posterior probability
 No effect
posterior probability
 Protective
posterior probability
  
D34 Benign neoplasm of thyroid gland
0.042 0.958 0.000
Y52 Agents primarily affecting the cardiovascular system
0.032 0.968 0.000
Y52.4 Angiotensin-converting-enzyme inhibitors
0.032 0.968 0.000
Y45.0 Opioids and related analgesics
0.030 0.970 0.000
S06.20 Diffuse brain injury (without open intracranial wound)
0.030 0.970 0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs
0.030 0.970 0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)
0.030 0.970 0.000
Y52.3 Coronary vasodilators, not elsewhere classified
0.029 0.971 0.000
S06.2 Diffuse brain injury
0.028 0.972 0.000
S06.6 Traumatic subarachnoid haemorrhage
0.028 0.972 0.000
S06 Intracranial injury
0.027 0.973 0.000
Y52.7 Peripheral vasodilators
0.027 0.973 0.000
Y51 Drugs primarily affecting the autonomic nervous system
0.027 0.973 0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified
0.026 0.974 0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified
0.026 0.974 0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system
0.026 0.974 0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]
0.026 0.974 0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use
0.026 0.974 0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified
0.026 0.974 0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs
0.025 0.975 0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified
0.025 0.975 0.000
Y45.2 Propionic acid derivatives
0.024 0.976 0.000
Y45.5 4-Aminophenol derivatives
0.024 0.976 0.000
Y53 Agents primarily affecting the gastro-intestinal system
0.024 0.976 0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system
0.023 0.977 0.000
Y52.8 Antivaricose drugs, including sclerosing agents
0.023 0.977 0.000
S06.5 Traumatic subdural haemorrhage
0.023 0.977 0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified
0.023 0.977 0.000
S06.8 Other intracranial injuries
0.023 0.977 0.000
Y41 Other systemic anti-infectives and antiparasitics
0.023 0.977 0.000
Y45.4 Antirheumatics
0.022 0.978 0.000
S06.0 Concussion
0.021 0.979 0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified
0.021 0.979 0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action
0.021 0.979 0.000
S06.1 Traumatic cerebral oedema
0.021 0.979 0.000
Y53.1 Other antacids and anti-gastric-secretion drugs
0.021 0.979 0.000
K90.0 Coeliac disease
0.021 0.979 0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs
0.021 0.979 0.000
S06.21 Diffuse brain injury (with open intracranial wound)
0.020 0.979 0.000
Y58 Bacterial vaccines
0.020 0.979 0.000
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)
0.020 0.979 0.000
Y46 Antiepileptics and anti-Parkinsonism drugs
0.020 0.980 0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system
0.020 0.980 0.000
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)
0.020 0.980 0.000
S06.9 Intracranial injury, unspecified
0.020 0.980 0.000
S06.7 Intracranial injury with prolonged coma
0.020 0.980 0.000
Y45.1 Salicylates
0.020 0.980 0.000
S06.4 Epidural haemorrhage
0.020 0.980 0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics
0.020 0.980 0.000
Y59 Other and unspecified vaccines and biological substances
0.019 0.980 0.000
Y50 Central nervous system stimulants, not elsewhere classified
0.019 0.981 0.000
S06.80 Other intracranial injuries (without open intracranial wound)
0.019 0.981 0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified
0.019 0.981 0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified
0.019 0.981 0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified
0.019 0.981 0.000
Y51.1 Other parasympathomimetics [cholinergics]
0.019 0.981 0.000
Y51.0 Anticholinesterase agents
0.019 0.981 0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system
0.019 0.981 0.000
Y52.1 Calcium-channel blockers
0.019 0.981 0.000
Y47 Sedatives, hypnotics and antianxiety drugs
0.019 0.981 0.000
Y49 Psychotropic drugs, not elsewhere classified
0.019 0.981 0.000
Y53.3 Saline and osmotic laxatives
0.017 0.982 0.000
Y45.8 Other analgesics and antipyretics
0.017 0.983 0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified
0.017 0.983 0.000
Y53.7 Emetics
0.017 0.983 0.000
Y53.6 Antidiarrhoeal drugs
0.017 0.983 0.000
Y53.5 Digestants
0.017 0.983 0.000
Y53.2 Stimulant laxatives
0.017 0.983 0.000
Y53.0 Histamine H2-receptor antagonists
0.017 0.983 0.000
Y41.1 Antimycobacterial drugs
0.017 0.983 0.000
Y41.5 Antiviral drugs
0.017 0.983 0.000
S06.00 Concussion (without open intracranial wound)
0.017 0.983 0.000
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)
0.017 0.983 0.000
Y53.4 Other laxatives
0.017 0.983 0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa
0.017 0.983 0.000
Y56.3 Emollients, demulcents and protectants
0.017 0.983 0.000
Y58.0 BCG vaccine
0.016 0.983 0.000
S06.81 Other intracranial injuries (with open intracranial wound)
0.016 0.983 0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified
0.016 0.983 0.000
Y41.4 Anthelminthics
0.016 0.983 0.000
Y41.3 Other antiprotozoal drugs
0.016 0.983 0.000
Y55.0 Oxytocic drugs
0.016 0.984 0.000
S06.10 Traumatic cerebral oedema (without open intracranial wound)
0.016 0.984 0.000
Y55.6 Antiasthmatics, not elsewhere classified
0.016 0.984 0.000
Y46.5 Valproic acid
0.016 0.984 0.000
S06.01 Concussion (with open intracranial wound)
0.015 0.984 0.000
Y46.2 Hydantoin derivatives
0.016 0.984 0.000
Y41.0 Sulphonamides
0.015 0.984 0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified
0.015 0.984 0.000
S06.3 Focal brain injury
0.015 0.984 0.000
Y46.4 Iminostilbenes
0.015 0.985 0.000
S06.11 Traumatic cerebral oedema (with open intracranial wound)
0.015 0.985 0.000
Y59.3 Immunoglobulin
0.015 0.985 0.000
Y46.6 Other and unspecified antiepileptics
0.015 0.985 0.000
Y56.9 Topical agent, unspecified
0.015 0.985 0.000
Y56.8 Other topical agents
0.015 0.985 0.000
Y56.7 Dental drugs, topically applied
0.015 0.985 0.000
Y56.6 Otorhinolaryngological drugs and preparations
0.015 0.985 0.000
Y56.5 Ophthalmological drugs and preparations
0.015 0.985 0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations
0.015 0.985 0.000
Y56.2 Local astringents and local detergents
0.015 0.985 0.000
Y56.1 Antipruritics
0.015 0.985 0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]
0.015 0.985 0.000
Y58.9 Other and unspecified bacterial vaccines
0.015 0.985 0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component
0.015 0.985 0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component
0.015 0.985 0.000
Y58.5 Diphtheria vaccine
0.015 0.985 0.000
Y58.4 Tetanus vaccine
0.015 0.985 0.000
Y58.3 Plague vaccine
0.015 0.985 0.000
Y58.2 Cholera vaccine
0.015 0.985 0.000
Y58.1 Typhoid and paratyphoid vaccine
0.015 0.985 0.000
Y46.8 Antispasticity drugs
0.015 0.985 0.000
Y46.3 Deoxybarbiturates
0.015 0.985 0.000
Y46.1 Oxazolidinediones
0.015 0.985 0.000
Y46.0 Succinimides
0.015 0.985 0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system
0.015 0.985 0.000
Y55.5 Anticommon cold drugs
0.015 0.985 0.000
Y55.3 Antitussives
0.015 0.985 0.000
Y55.2 Other and unspecified agents primarily acting on muscles
0.015 0.985 0.000
S06.90 Intracranial injury, unspecified (without open intracranial wound)
0.015 0.985 0.000
Y49.5 Other antipsychotics and neuroleptics
0.015 0.985 0.000
S06.91 Intracranial injury, unspecified (with open intracranial wound)
0.014 0.985 0.000
S06.71 Intracranial injury with prolonged coma (with open intracranial wound)
0.014 0.985 0.000
S06.70 Intracranial injury with prolonged coma (without open intracranial wound)
0.014 0.985 0.000
Y50.2 Methylxanthines, not elsewhere classified
0.014 0.986 0.000
S06.41 Epidural haemorrhage (with open intracranial wound)
0.014 0.986 0.000
Y59.9 Vaccine or biological substance, unspecified
0.014 0.986 0.000
Y59.8 Other specified vaccines and biological substances
0.014 0.986 0.000
Y59.2 Protozoal vaccines
0.014 0.986 0.000
Y59.1 Rickettsial vaccines
0.014 0.986 0.000
S06.40 Epidural haemorrhage (without open intracranial wound)
0.014 0.986 0.000
Y50.9 Central nervous system stimulant, unspecified
0.014 0.986 0.000
Y50.8 Other central nervous system stimulants
0.014 0.986 0.000
Y50.1 Opioid receptor antagonists
0.014 0.986 0.000
Y50.0 Analeptics
0.014 0.986 0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified
0.014 0.986 0.000
Y46.7 Anti-Parkinsonism drugs
0.014 0.986 0.000
Y59.0 Viral vaccines
0.014 0.986 0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics
0.014 0.986 0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified
0.014 0.986 0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs
0.014 0.986 0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified
0.014 0.986 0.000
Y47.4 Bromine compounds
0.014 0.986 0.000
Y47.3 Paraldehyde
0.014 0.986 0.000
Y47.2 Chloral derivatives
0.014 0.986 0.000
Y47.0 Barbiturates, not elsewhere classified
0.014 0.986 0.000
Y49.9 Psychotropic drug, unspecified
0.013 0.986 0.000
Y49.7 Psychostimulants with abuse potential
0.013 0.986 0.000
Y49.6 Psychodysleptics [hallucinogens]
0.013 0.986 0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics
0.013 0.986 0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants
0.013 0.986 0.000
Y47.1 Benzodiazepines
0.013 0.987 0.000
Y49.8 Other psychotropic drugs, not elsewhere classified
0.013 0.987 0.000
Y57 Other and unspecified drugs and medicaments
0.013 0.987 0.000
Y49.0 Tricyclic and tetracyclic antidepressants
0.013 0.987 0.000
Y55.4 Expectorants
0.013 0.987 0.000
Y48 Anaesthetics and therapeutic gases
0.012 0.988 0.000
Y49.2 Other and unspecified antidepressants
0.012 0.988 0.000
Y43 Primarily systemic agents
0.012 0.988 0.000
S06.31 Focal brain injury (with open intracranial wound)
0.011 0.989 0.000
H55 Nystagmus and other irregular eye movements
0.000 0.990 0.010
Y57.6 Other diagnostic agents
0.010 0.990 0.000
Y43.0 Antiallergic and antiemetic drugs
0.010 0.990 0.000
Y43.2 Antineoplastic natural products
0.010 0.990 0.000
R52.1 Chronic intractable pain
0.010 0.990 0.000
Y57.7 Vitamins, not elsewhere classified
0.010 0.990 0.000
Y57.4 Pharmaceutical excipients
0.010 0.990 0.000
Y57.3 Alcohol deterrents
0.010 0.990 0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified
0.010 0.990 0.000
Y57.1 Lipotropic drugs
0.010 0.990 0.000
Y57.0 Appetite depressants [anorectics]
0.010 0.990 0.000
Y48.5 Therapeutic gases
0.009 0.991 0.000
Y48.1 Parenteral anaesthetics
0.009 0.991 0.000
Y48.0 Inhaled anaesthetics
0.009 0.991 0.000
Y43.9 Primarily systemic agent, unspecified
0.009 0.991 0.000
Y43.8 Other primarily systemic agents, not elsewhere classified
0.009 0.991 0.000
Y43.6 Enzymes, not elsewhere classified
0.009 0.991 0.000
Y43.5 Acidifying and alkalising agents
0.009 0.991 0.000
C50.1 Central portion of breast
0.009 0.991 0.000
Y57.9 Drug or medicament, unspecified
0.009 0.991 0.000
Y44 Agents primarily affecting blood constituents
0.009 0.991 0.000
Y48.4 Anaesthetic, unspecified
0.008 0.992 0.000
Y57.8 Other drugs and medicaments
0.008 0.992 0.000
K90 Intestinal malabsorption
0.008 0.992 0.000
Y43.4 Immunosuppressive agents
0.008 0.992 0.000
Y43.1 Antineoplastic antimetabolites
0.008 0.992 0.000
Y48.3 Local anaesthetics
0.007 0.992 0.000
S06.30 Focal brain injury (without open intracranial wound)
0.007 0.993 0.000
Y48.2 Other and unspecified general anaesthetics
0.007 0.993 0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism
0.007 0.993 0.000
Y57.5 X-ray contrast media
0.007 0.993 0.000
K90.9 Intestinal malabsorption, unspecified
0.007 0.993 0.000
Y44.9 Other and unspecified agents affecting blood constituents
0.006 0.993 0.000
Y44.7 Plasma substitutes
0.006 0.993 0.000
Y44.6 Natural blood and blood products
0.006 0.993 0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations
0.006 0.993 0.000
Y44.5 Thrombolytic drugs
0.006 0.993 0.000
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
0.000 0.994 0.006
Q85.0 Neurofibromatosis (nonmalignant)
0.000 0.994 0.006
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations
0.006 0.994 0.000
G06 Intracranial and intraspinal abscess and granuloma
0.000 0.994 0.006
G06.1 Intraspinal abscess and granuloma
0.000 0.994 0.006
K90.3 Pancreatic steatorrhoea
0.006 0.994 0.000
K90.2 Blind loop syndrome, not elsewhere classified
0.006 0.994 0.000
K90.1 Tropical sprue
0.006 0.994 0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]
0.006 0.994 0.000
G93.0 Cerebral cysts
0.000 0.994 0.006
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants
0.005 0.994 0.000
N99.3 Prolapse of vaginal vault after hysterectomy
0.006 0.994 0.000
G00-G09 Inflammatory diseases of the central nervous system
0.000 0.994 0.006
G80.9 Infantile cerebral palsy, unspecified
0.005 0.995 0.000
M79.70 Fibromyalgia (Multiple sites)
0.000 0.995 0.005
G04 Encephalitis, myelitis and encephalomyelitis
0.000 0.995 0.005
K90.4 Malabsorption due to intolerance, not elsewhere classified
0.005 0.995 0.000
O99.0 Anaemia complicating pregnancy, childbirth and the puerperium
0.000 0.995 0.005
G06.2 Extradural and subdural abscess, unspecified
0.000 0.995 0.005
G06.0 Intracranial abscess and granuloma
0.000 0.995 0.005
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]
0.005 0.995 0.000
Y54.9 Mineral salts, not elsewhere classified
0.005 0.995 0.000
Y54.6 Electrolytic, caloric and water-balance agents
0.005 0.995 0.000
Y54.2 Carbonic-anhydrase inhibitors
0.005 0.995 0.000
K90.8 Other intestinal malabsorption
0.005 0.995 0.000
G04.9 Encephalitis, myelitis and encephalomyelitis, unspecified
0.000 0.995 0.005
H74.8 Other specified disorders of middle ear and mastoid
0.005 0.995 0.000
G09 Sequelae of inflammatory diseases of central nervous system
0.000 0.995 0.005
Y54.0 Mineralocorticoids
0.005 0.995 0.000
Y54.7 Agents affecting calcification
0.005 0.995 0.000
A49.0 Staphylococcal infection, unspecified
0.000 0.995 0.005
G00 Bacterial meningitis, not elsewhere classified
0.000 0.995 0.005
G01 Meningitis in bacterial diseases classified elsewhere
0.000 0.995 0.005
M43.02 Spondylolysis (Cervical region)
0.000 0.995 0.005
Y54.8 Agents affecting uric acid metabolism
0.004 0.995 0.000
Y54.4 Loop [high-ceiling] diuretics
0.004 0.995 0.000
G08 Intracranial and intraspinal phlebitis and thrombophlebitis
0.000 0.995 0.005
K12.3 Oral mucositis (ulcerative)
0.004 0.996 0.000
G00.9 Bacterial meningitis, unspecified
0.000 0.996 0.004
G04.0 Acute disseminated encephalitis
0.000 0.996 0.004
R52.0 Acute pain
0.004 0.996 0.000
G07 Intracranial and intraspinal abscess and granuloma in diseases classified elsewhere
0.000 0.996 0.004
I44.0 Atrioventricular block, first degree
0.004 0.996 0.000
G04.8 Other encephalitis, myelitis and encephalomyelitis
0.000 0.996 0.004
G04.2 Bacterial meningoencephalitis and meningomyelitis, not elsewhere classified
0.000 0.996 0.004
G04.1 Tropical spastic paraplegia
0.000 0.996 0.004
R50.0 Fever with chills
0.004 0.996 0.000
O63.1 Prolonged second stage (of labour)
0.004 0.996 0.000
R52 Pain, not elsewhere classified
0.004 0.996 0.000
Z41.1 Other plastic surgery for unacceptable cosmetic appearance
0.004 0.996 0.000
G80 Infantile cerebral palsy
0.004 0.996 0.000
G02 Meningitis in other infectious and parasitic diseases classified elsewhere
0.000 0.996 0.004
G00.2 Streptococcal meningitis
0.000 0.996 0.004
M79.7 Fibromyalgia
0.000 0.996 0.004
G00.1 Pneumococcal meningitis
0.000 0.996 0.004
Q21.1 Atrial septal defect
0.000 0.996 0.004
G00.3 Staphylococcal meningitis
0.000 0.996 0.004
G00.0 Haemophilus meningitis
0.000 0.996 0.004
Y40 Systemic antibiotics
0.004 0.996 0.000
M79.79 Fibromyalgia (Site unspecified)
0.000 0.996 0.004
G05 Encephalitis, myelitis and encephalomyelitis in diseases classified elsewhere
0.000 0.996 0.003
M79.19 Myalgia (Site unspecified)
0.000 0.996 0.004
G00.8 Other bacterial meningitis
0.000 0.996 0.003
G80.2 Infantile hemiplegia
0.003 0.996 0.000
G80.1 Spastic diplegia
0.003 0.997 0.000
Y54.5 Other diuretics
0.003 0.997 0.001
G03 Meningitis due to other and unspecified causes
0.000 0.997 0.003
M19.98 Arthrosis, unspecified (Other)
0.003 0.997 0.000
G80.0 Spastic cerebral palsy
0.003 0.997 0.000
Q85 Phakomatoses, not elsewhere classified
0.000 0.997 0.003
C83.3 Large cell (diffuse)
0.003 0.997 0.000
Y40.7 Antifungal antibiotics, systemically used
0.003 0.997 0.000
G80.4 Ataxic cerebral palsy
0.003 0.997 0.000
G80.3 Dyskinetic cerebral palsy
0.003 0.997 0.000
M79.78 Fibromyalgia (Other)
0.000 0.997 0.003
M79.77 Fibromyalgia (Ankle and foot)
0.000 0.997 0.003
M79.76 Fibromyalgia (Lower leg)
0.000 0.997 0.003
M79.75 Fibromyalgia (Pelvic region and thigh)
0.000 0.997 0.003
M79.74 Fibromyalgia (Hand)
0.000 0.997 0.003
M79.73 Fibromyalgia (Forearm)
0.000 0.997 0.003
M79.72 Fibromyalgia (Upper arm)
0.000 0.997 0.003
M79.71 Fibromyalgia (Shoulder region)
0.000 0.997 0.003
G02.8 Meningitis in other specified infectious and parasitic diseases classified elsewhere
0.000 0.997 0.003
G02.1 Meningitis in mycoses
0.000 0.997 0.003
Y40.4 Tetracyclines
0.003 0.997 0.000
J30.3 Other allergic rhinitis
0.003 0.997 0.000
G80.8 Other infantile cerebral palsy
0.003 0.997 0.000
Y54.3 Benzothiadiazine derivatives
0.002 0.997 0.001
J67.9 Hypersensitivity pneumonitis due to unspecified organic dust
0.003 0.997 0.000
K70.9 Alcoholic liver disease, unspecified
0.000 0.997 0.003
Q85.8 Other phakomatoses, not elsewhere classified
0.000 0.997 0.003
W20.0 Home
0.003 0.997 0.000
Y40.2 Chloramphenicol group
0.003 0.997 0.000
W20 Struck by thrown, projected or falling object
0.003 0.997 0.000
G05.8 Encephalitis, myelitis and encephalomyelitis in other diseases classified elsewhere
0.000 0.997 0.003
G05.2 Encephalitis, myelitis and encephalomyelitis in other infectious and parasitic diseases classified elsewhere
0.000 0.997 0.003
G05.0 Encephalitis, myelitis and encephalomyelitis in bacterial diseases classified elsewhere
0.000 0.997 0.003
H74.9 Disorder of middle ear and mastoid, unspecified
0.003 0.997 0.000
Y40.3 Macrolides
0.003 0.997 0.000
R44.3 Hallucinations, unspecified
0.003 0.997 0.000
M43.17 Spondylolisthesis (Lumbosacral region)
0.000 0.997 0.003
C80.9 Malignant neoplasm, unspecified
0.000 0.997 0.003
Y40.6 Rifamycins
0.003 0.997 0.000
M79.1 Myalgia
0.000 0.997 0.003
W20.8 Other specified place
0.003 0.997 0.000
W22.9 Unspecified place
0.003 0.997 0.000
J10.1 Influenza with other respiratory manifestations, influenza virus identified
0.003 0.997 0.000
G02.0 Meningitis in viral diseases classified elsewhere
0.000 0.997 0.003
M79.11 Myalgia (Shoulder region)
0.000 0.997 0.003
G03.8 Meningitis due to other specified causes
0.000 0.997 0.003
G03.2 Benign recurrent meningitis [Mollaret]
0.000 0.997 0.003
G03.1 Chronic meningitis
0.000 0.997 0.003
G03.0 Nonpyogenic meningitis
0.000 0.997 0.003
W21.9 Unspecified place
0.003 0.997 0.000
L65.9 Nonscarring hair loss, unspecified
0.000 0.997 0.003
Q85.9 Phakomatosis, unspecified
0.000 0.997 0.003
X41.9 Unspecified place
0.003 0.997 0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified
0.003 0.997 0.000
W22 Striking against or struck by other objects
0.003 0.997 0.000
Q18.0 Sinus, fistula and cyst of branchial cleft
0.000 0.997 0.003
W07.0 Home
0.003 0.997 0.000
H74 Other disorders of middle ear and mastoid
0.003 0.997 0.000
C79.7 Secondary malignant neoplasm of adrenal gland
0.003 0.997 0.000
M79.15 Myalgia (Pelvic region and thigh)
0.000 0.997 0.003
C90.2 Plasmacytoma, extramedullary
0.003 0.997 0.000
J67.2 Bird fancier's lung
0.003 0.997 0.000
C83 Diffuse non-Hodgkin's lymphoma
0.003 0.997 0.000
W21 Striking against or struck by sports equipment
0.002 0.997 0.000
Q85.1 Tuberous sclerosis
0.000 0.997 0.002
W40 Explosion of other materials
0.002 0.997 0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)
0.000 0.998 0.002
W22.3 Sports and athletics area
0.002 0.998 0.000
W20-W49 Exposure to inanimate mechanical forces
0.002 0.998 0.000
M79.16 Myalgia (Lower leg)
0.000 0.998 0.002
C83.2 Mixed small and large cell (diffuse)
0.002 0.998 0.000
M43.0 Spondylolysis
0.000 0.998 0.002
H74.3 Other acquired abnormalities of ear ossicles
0.002 0.998 0.000
W20.3 Sports and athletics area
0.002 0.998 0.000
Y44.2 Anticoagulants
0.002 0.998 0.001
A46 Erysipelas
0.000 0.998 0.002
W07.9 Unspecified place
0.002 0.998 0.000
W40.9 Unspecified place
0.002 0.998 0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma
0.002 0.998 0.000
C83.1 Small cleaved cell (diffuse)
0.002 0.998 0.000
H49.9 Paralytic strabismus, unspecified
0.000 0.998 0.002
H74.2 Discontinuity and dislocation of ear ossicles
0.002 0.998 0.000
W20.9 Unspecified place
0.002 0.998 0.000
W20.6 Industrial and construction area
0.002 0.998 0.000
W20.5 Trade and service area
0.002 0.998 0.000
W20.4 Street and highway
0.002 0.998 0.000
W20.2 School, other institution and public administrative area
0.002 0.998 0.000
W20.7 Farm
0.002 0.998 0.000
W20.1 Residential institution
0.002 0.998 0.000
Y42.2 Antithyroid drugs
0.002 0.998 0.000
E78.9 Disorder of lipoprotein metabolism, unspecified
0.002 0.998 0.000
W23 Caught, crushed, jammed or pinched in or between objects
0.002 0.998 0.000
G05.1 Encephalitis, myelitis and encephalomyelitis in viral diseases classified elsewhere
0.000 0.998 0.002
J67 Hypersensitivity pneumonitis due to organic dust
0.002 0.998 0.000
M79.17 Myalgia (Ankle and foot)
0.000 0.998 0.002
M79.14 Myalgia (Hand)
0.000 0.998 0.002
M79.13 Myalgia (Forearm)
0.000 0.998 0.002
M79.12 Myalgia (Upper arm)
0.000 0.998 0.002
Y42.4 Oral contraceptives
0.002 0.998 0.000
J10.0 Influenza with pneumonia, influenza virus identified
0.002 0.998 0.000
W07 Fall involving chair
0.002 0.998 0.000
F01.9 Vascular dementia, unspecified
0.002 0.998 0.000
Y40.5 Aminoglycosides
0.002 0.998 0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs
0.002 0.998 0.000
C97 Malignant neoplasms of independent (primary) multiple sites
0.000 0.998 0.002
W26 Contact with knife, sword or dagger
0.002 0.998 0.000
S92.30 Fracture of metatarsal bone (closed)
0.000 0.998 0.002
C83.5 Lymphoblastic (diffuse)
0.002 0.998 0.000
H74.1 Adhesive middle ear disease
0.002 0.998 0.000
H80.9 Otosclerosis, unspecified
0.000 0.998 0.002
W40.0 Home
0.002 0.998 0.000
M23.89 Other internal derangements of knee (Unspecified ligament or Unspecified meniscus)
0.000 0.998 0.002
W22.2 School, other institution and public administrative area
0.002 0.998 0.000
W23.2 School, other institution and public administrative area
0.002 0.998 0.000
W07.5 Trade and service area
0.002 0.998 0.000
C18.2 Ascending colon
0.002 0.998 0.000
W22.8 Other specified place
0.002 0.998 0.000
W22.6 Industrial and construction area
0.002 0.998 0.000
W22.4 Street and highway
0.002 0.998 0.000
W22.0 Home
0.002 0.998 0.000
W22.7 Farm
0.002 0.998 0.000
W22.1 Residential institution
0.002 0.998 0.000
Z41 Procedures for purposes other than remedying health state
0.002 0.998 0.000
W23.3 Sports and athletics area
0.002 0.998 0.000
Y40.9 Systemic antibiotic, unspecified
0.002 0.998 0.000
Y60.4 During endoscopic examination
0.002 0.998 0.000
W26.8 Other specified place
0.002 0.998 0.000
Y40.1 Cefalosporins and other -lactam antibiotics
0.002 0.998 0.000
W27 Contact with nonpowered hand tool
0.002 0.998 0.000
C83.6 Undifferentiated (diffuse)
0.002 0.998 0.000
C83.4 Immunoblastic (diffuse)
0.002 0.998 0.000
R45.8 Other symptoms and signs involving emotional state
0.002 0.998 0.000
R52.2 Other chronic pain
0.002 0.998 0.000
W21.0 Home
0.002 0.998 0.000
F05.8 Other delirium
0.002 0.998 0.000
N81.4 Uterovaginal prolapse, unspecified
0.000 0.998 0.002
M79.29 Neuralgia and neuritis, unspecified (Site unspecified)
0.000 0.998 0.002
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified
0.002 0.998 0.000
H49.0 Third [oculomotor] nerve palsy
0.000 0.998 0.002
W21.3 Sports and athletics area
0.002 0.998 0.000
W21.7 Farm
0.002 0.998 0.000
W21.6 Industrial and construction area
0.002 0.998 0.000
W21.5 Trade and service area
0.002 0.998 0.000
W21.4 Street and highway
0.002 0.998 0.000
W21.2 School, other institution and public administrative area
0.002 0.998 0.000
W21.1 Residential institution
0.002 0.998 0.000
J67.8 Hypersensitivity pneumonitis due to other organic dusts
0.002 0.998 0.000
W40.8 Other specified place
0.002 0.998 0.000
W40.7 Farm
0.002 0.998 0.000
W40.6 Industrial and construction area
0.002 0.998 0.000
W40.5 Trade and service area
0.002 0.998 0.000
W40.4 Street and highway
0.002 0.998 0.000
W40.3 Sports and athletics area
0.002 0.998 0.000
W40.2 School, other institution and public administrative area
0.002 0.998 0.000
W40.1 Residential institution
0.002 0.998 0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)
0.000 0.998 0.002
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified
0.002 0.998 0.000
W46 Contact with hypodermic needle
0.002 0.998 0.000
W43 Exposure to vibration
0.002 0.998 0.000
W42 Exposure to noise
0.002 0.998 0.000
W41 Exposure to high-pressure jet
0.002 0.998 0.000
W39 Discharge of firework
0.002 0.998 0.000
W38 Explosion and rupture of other specified pressurised devices
0.002 0.998 0.000
W37 Explosion and rupture of pressurised tyre, pipe or hose
0.002 0.998 0.000
W36 Explosion and rupture of gas cylinder
0.002 0.998 0.000
W35 Explosion and rupture of boiler
0.002 0.998 0.000
W33 Rifle, shotgun and larger firearm discharge
0.002 0.998 0.000
W32 Handgun discharge
0.002 0.998 0.000
W30 Contact with agricultural machinery
0.002 0.998 0.000
M43.08 Spondylolysis (Sacral and sacrococcygeal region)
0.000 0.998 0.002
M43.05 Spondylolysis (Thoracolumbar region)
0.000 0.998 0.002
M43.04 Spondylolysis (Thoracic region)
0.000 0.998 0.002
M43.03 Spondylolysis (Cervicothoracic region)
0.000 0.998 0.002
M43.01 Spondylolysis (Occipito-atlanto-axial region)
0.000 0.998 0.002
M43.00 Spondylolysis (Multiple sites in spine)
0.000 0.998 0.002
M81.90 Osteoporosis, unspecified (Multiple sites)
0.002 0.998 0.000
H49 Paralytic strabismus
0.000 0.998 0.002
Z41.8 Other procedures for purposes other than remedying health state
0.002 0.998 0.000
W34 Discharge from other and unspecified firearms
0.002 0.998 0.000
W22.5 Trade and service area
0.002 0.998 0.000
C90 Multiple myeloma and malignant plasma cell neoplasms
0.002 0.998 0.000
J10 Influenza due to identified influenza virus
0.002 0.998 0.000
W31 Contact with other and unspecified machinery
0.002 0.998 0.000
W20.22 Struck by thrown, projected or falling object; School, other institution and public administrative area ;While working for income
0.002 0.998 0.000
W20.49 Struck by thrown, projected or falling object; Street and highway;During unspecified activity
0.002 0.998 0.000
W20.52 Struck by thrown, projected or falling object; Trade and service area;While working for income
0.002 0.998 0.000
W20.62 Struck by thrown, projected or falling object; Industrial and construction area ;While working for income
0.002 0.998 0.000
W20.99 Struck by thrown, projected or falling object; Unspecified place ;During unspecified activity
0.002 0.998 0.000
W20.92 Struck by thrown, projected or falling object, Unspecified place, While working for income
0.002 0.998 0.000
Y42.9 Other and unspecified hormone antagonists
0.002 0.998 0.000
X41 Accidental poisoning by and exposure to antiepileptic, sedative-hypnotic, anti-Parkinsonism and psychotropic drugs, not elsewhere classified
0.002 0.998 0.000
W21.8 Other specified place
0.002 0.998 0.000
W23.9 Unspecified place
0.002 0.998 0.000
W23.8 Other specified place
0.002 0.998 0.000
W23.6 Industrial and construction area
0.002 0.998 0.000
W23.5 Trade and service area
0.002 0.998 0.000
W23.0 Home
0.002 0.998 0.000
W23.7 Farm
0.002 0.998 0.000
W23.1 Residential institution
0.002 0.998 0.000
M25.75 Osteophyte (Pelvic region and thigh)
0.000 0.998 0.002
M43.07 Spondylolysis (Lumbosacral region)
0.000 0.998 0.002
C83.7 Burkitt's tumour
0.002 0.998 0.000
G03.9 Meningitis, unspecified
0.000 0.998 0.002
J67.7 Air-conditioner and humidifier lung
0.002 0.998 0.000
J67.6 Maple-bark-stripper's lung
0.002 0.998 0.000
J67.5 Mushroom-worker's lung
0.002 0.998 0.000
J67.4 Maltworker's lung
0.002 0.998 0.000
J67.3 Suberosis
0.002 0.998 0.000
J67.1 Bagassosis
0.002 0.998 0.000
J67.0 Farmer's lung
0.002 0.998 0.000
W07.8 Other specified place
0.002 0.998 0.000
W24 Contact with lifting and transmission devices, not elsewhere classified
0.002 0.998 0.000
C90.0 Multiple myeloma
0.002 0.998 0.000
N08.3 Glomerular disorders in diabetes mellitus
0.002 0.998 0.000
M43.09 Spondylolysis (Site unspecified)
0.000 0.998 0.002
M79.18 Myalgia (Other)
0.000 0.998 0.002
K70.1 Alcoholic hepatitis
0.000 0.998 0.002
W07.2 School, other institution and public administrative area
0.002 0.998 0.000
W07.7 Farm
0.002 0.998 0.000
W07.6 Industrial and construction area
0.002 0.998 0.000
W07.4 Street and highway
0.002 0.998 0.000
W07.3 Sports and athletics area
0.002 0.998 0.000
Y42.1 Thyroid hormones and substitutes
0.002 0.998 0.000
Z41.9 Procedures for purposes other than remedying health state, unspecified
0.002 0.998 0.000
E80.4 Gilbert's syndrome
0.000 0.998 0.002
H50.9 Strabismus, unspecified
0.000 0.998 0.002
W26.9 Unspecified place
0.002 0.998 0.000
W26.5 Trade and service area
0.002 0.998 0.000
W26.0 Home
0.002 0.998 0.000
W26.7 Farm
0.002 0.998 0.000
W26.6 Industrial and construction area
0.002 0.998 0.000
W26.4 Street and highway
0.002 0.998 0.000
W26.3 Sports and athletics area
0.002 0.998 0.000
W26.2 School, other institution and public administrative area
0.002 0.998 0.000
W26.1 Residential institution
0.002 0.998 0.000
Q21 Congenital malformations of cardiac septa
0.000 0.998 0.002
W29 Contact with other powered hand tools and household machinery
0.002 0.998 0.000
H81.9 Disorder of vestibular function, unspecified
0.000 0.998 0.002
J14 Pneumonia due to Haemophilus influenzae
0.000 0.998 0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

 

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

This website was created, designed, and edited by ORCID iD iconPatrick K. Albers

The contents of TreeWAS.org are available under the Creative Commons Attribution 4.0 International License (CC BY 4.0) with attribution (citation) required.

TreeWAS Database © 2019 - 2024 About Frequently Asked Questions Citation Contact Terms & Conditions This website does not use cookies to collect any personal information about you.